Company Info

TIMA Establishment

TIMA Establishment
Address Alte Churer Strasse 45 FL-9496 Balzers Liechtenstein
Representative Markus Count Matuschka de Greiffenclau


TIMA Tokyo INC was spun off and established in 2019 as the manufacturing and sales company for Oxicut in Japan.

The TIMA Medical Foundation has been supporting medical research and development around the world, especially in areas that are not covered by major pharmaceutical companies.
To date, TIMA has supported projects such as gene therapy for glioma brain tumors, research on reducing the health hazards of alcohol, research on metabolic syndrome (mainly diabetes), inhibition of reactive oxygen species (anti-aging), and development of new antibacterial drugs that do not develop drug resistance.
These researches are mainly based on the results of the research team led by Haruhiko Inufusa.

Established June 21, 2019
Representative CEO Sho Tanaka

・Tokyo Head Office
3F-2-28-3 Ebisu, Shibuya-ku, Tokyo, Japan

・Osaka branch
404-1-9-1 Minamisemba, Chuo-ku, Osaka, Japan

Capital JPY 8 million
Major shareholders European Medical Foundation TIMA Establishment
Business description Manufacturing and sales of Twendee X, Twendee MTcontrol and SUPALIV

Department of Antioxidant Research, Tokai National University Organization Gifu University, Japan,

Special Professor:Haruhiko Inufusa
Location: 501-1194, 7th Floor, Faculty of Medicine Building 7S33, 1-1 Yanato, Gifu-shi, Gifu, Japan

All of our products are developed in Gifu National University.